Double sustained release biological agent for tumor local ablation therapy
A dual slow-release, biological preparation technology, applied in the field of biopharmaceutical technology, to achieve the effects of avoiding toxic and side effects, convenient operation, and alleviating pain
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0041] The double sustained-release biological preparation of this embodiment is used for the following injections against human liver cancer, breast cancer, prostate cancer nude mice or against mouse cervical cancer, melanoma, S180 sarcoma or for the treatment of rabbit orthotopic liver VX2 tumors or other tumors , the total amount of this formula is 7 ml, and the concentration of the selected temperature-sensitive gel is 20%. Contains norepinephrine 25μg, ricin 0.25μg, cobra venom cytotoxin 5μg.
Embodiment 2
[0043] The double sustained-release biological preparation of this embodiment is used for the following injections against human liver cancer, breast cancer, prostate cancer nude mice or against mouse cervical cancer, melanoma, S180 sarcoma or for the treatment of rabbit orthotopic liver VX2 tumors or other tumors , the total amount of this formula is 6 ml, and the concentration of the selected temperature-sensitive gel is 25%. Contains norepinephrine 50μg, ricin 0.5μg, cobra venom cytotoxin 10μg.
Embodiment 3
[0045] The double sustained-release biological preparation of this embodiment is used for the following injections against human liver cancer, breast cancer, prostate cancer nude mice or against mouse cervical cancer, melanoma, S180 sarcoma or for the treatment of rabbit orthotopic liver VX2 tumors or other tumors The total amount of this formula is 10 milliliters, and the concentration of the selected temperature-sensitive gel is 30%. The preparation method of this component is the same as the preparation method of the above-mentioned "5". The gel contains 75 μg of norepinephrine, 0.75 μg of ricin, and 15 μg of cobra venom cytotoxin.
[0046]The total amount of the dual sustained-release biological formulations in the above examples can be taken as needed, that is, it can be prepared according to the required amount for injecting anti-human liver cancer nude mice or treating rabbit orthotopic liver VX2 tumors or other tumors.
[0047] 8. Acute Toxicity Test of Dual Sustained-...
PUM
Property | Measurement | Unit |
---|---|---|
particle diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com